Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Lisa Bero to Conflict of Interest

This is a "connection" page, showing publications Lisa Bero has written about Conflict of Interest.

 
Connection Strength
  
 
 
22.034
  
  1. Parker L, Bero L. Managing risk from conflicts of interest in guideline development committees. BMJ. 2022 12 06; 379:e072252.
    View in: PubMed
    Score: 0.723
  2. Moynihan R, Albarqouni L, Nangla C, Dunn AG, Lexchin J, Bero L. Financial ties between leaders of influential US professional medical associations and industry: cross sectional study. BMJ. 2020 05 27; 369:m1505.
    View in: PubMed
    Score: 0.607
  3. Moynihan R, Fabbri A, Parker L, Bero L. Mixed methods evaluation of workshops for citizen health advocates about financial conflicts of interests in healthcare. BMJ Open. 2020 05 10; 10(5):e034195.
    View in: PubMed
    Score: 0.605
  4. Grundy Q, Mazzarello S, Bero L. A comparison of policy provisions for managing "financial" and "non-financial" interests across health-related research organizations: A qualitative content analysis. Account Res. 2020 05; 27(4):212-237.
    View in: PubMed
    Score: 0.601
  5. Grundy Q, Dunn AG, Bero L. Improving researchers' conflict of interest declarations. BMJ. 2020 Mar 11; 368:m422.
    View in: PubMed
    Score: 0.598
  6. Karanges EA, Ting N, Parker L, Fabbri A, Bero L. Pharmaceutical industry payments to leaders of professional medical associations in Australia: Focus on cardiovascular disease and diabetes. Aust J Gen Pract. 2020 03; 49(3):151-154.
    View in: PubMed
    Score: 0.597
  7. Grundy Q, Mayes C, Holloway K, Mazzarello S, Thombs BD, Bero L. Conflict of interest as ethical shorthand: understanding the range and nature of "non-financial conflict of interest" in biomedicine. J Clin Epidemiol. 2020 04; 120:1-7.
    View in: PubMed
    Score: 0.588
  8. Parker L, Fabbri A, Grundy Q, Mintzes B, Bero L. "Asset exchange"-interactions between patient groups and pharmaceutical industry: Australian qualitative study. BMJ. 2019 12 12; 367:l6694.
    View in: PubMed
    Score: 0.588
  9. Bero L, Hr?bjartsson A, Grundy Q. Response to Soares et al. Eur J Clin Nutr. 2020 02; 74(2):351-352.
    View in: PubMed
    Score: 0.587
  10. Baur X, Soskolne CL, Bero LA. How can the integrity of occupational and environmental health research be maintained in the presence of conflicting interests? Environ Health. 2019 11 04; 18(1):93.
    View in: PubMed
    Score: 0.583
  11. Kearns CE, Bero LA. Conflicts of interest between the sugary food and beverage industry and dental research organisations: time for reform. Lancet. 2019 07 20; 394(10194):194-196.
    View in: PubMed
    Score: 0.572
  12. Moynihan R, Lai A, Jarvis H, Duggan G, Goodrick S, Beller E, Bero L. Undisclosed financial ties between guideline writers and pharmaceutical companies: a cross-sectional study across 10 disease categories. BMJ Open. 2019 02 05; 9(2):e025864.
    View in: PubMed
    Score: 0.554
  13. Fabbri A, Holland TJ, Bero LA. Food industry sponsorship of academic research: investigating commercial bias in the research agenda. Public Health Nutr. 2018 12; 21(18):3422-3430.
    View in: PubMed
    Score: 0.538
  14. Bero L, Grundy Q. Conflicts of Interest in Nutrition Research. JAMA. 2018 07 03; 320(1):93-94.
    View in: PubMed
    Score: 0.532
  15. Parker L, Grundy Q, Bero L. Interpreting evidence in general practice: Bias and conflicts of interest. Aust J Gen Pract. 2018 06; 47(6):337-340.
    View in: PubMed
    Score: 0.529
  16. Bero LA, Grundy Q. Not All Influences on Science Are Conflicts of Interest. Am J Public Health. 2018 05; 108(5):632-633.
    View in: PubMed
    Score: 0.525
  17. Mintzes B, Swandari S, Fabbri A, Grundy Q, Moynihan R, Bero L. Does industry-sponsored education foster overdiagnosis and overtreatment of depression, osteoporosis and over-active bladder syndrome? An Australian cohort study. BMJ Open. 2018 02 13; 8(2):e019027.
    View in: PubMed
    Score: 0.518
  18. Grundy Q, Dunn AG, Bourgeois FT, Coiera E, Bero L. Prevalence of Disclosed Conflicts of Interest in Biomedical Research and Associations With Journal Impact Factors and Altmetric Scores. JAMA. 2018 01 23; 319(4):408-409.
    View in: PubMed
    Score: 0.516
  19. Cosgrove L, Shaughnessy AF, Peters SM, Lexchin JR, Bursztajn H, Bero L. Conflicts of Interest and the Presence of Methodologists on Guideline Development Panels: A Cross-Sectional Study of Clinical Practice Guidelines for Major Depressive Disorder. Psychother Psychosom. 2017; 86(3):168-170.
    View in: PubMed
    Score: 0.491
  20. Bero L. Addressing Bias and Conflict of Interest Among Biomedical Researchers. JAMA. 2017 May 02; 317(17):1723-1724.
    View in: PubMed
    Score: 0.490
  21. Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L. Industry sponsorship and research outcome. Cochrane Database Syst Rev. 2017 02 16; 2:MR000033.
    View in: PubMed
    Score: 0.483
  22. Lundh A, Bero L. The ties that bind. BMJ. 2017 Jan 17; 356:j176.
    View in: PubMed
    Score: 0.481
  23. Bero LA, Grundy Q. Why Having a (Nonfinancial) Interest Is Not a Conflict of Interest. PLoS Biol. 2016 Dec; 14(12):e2001221.
    View in: PubMed
    Score: 0.478
  24. Grundy Q, Fabbri A, Mintzes B, Swandari S, Bero L. The Inclusion of Nurses in Pharmaceutical Industry-Sponsored Events: Guess Who Is Also Coming to Dinner? JAMA Intern Med. 2016 11 01; 176(11):1718-1720.
    View in: PubMed
    Score: 0.474
  25. Mandrioli D, Kearns CE, Bero LA. Relationship between Research Outcomes and Risk of Bias, Study Sponsorship, and Author Financial Conflicts of Interest in Reviews of the Effects of Artificially Sweetened Beverages on Weight Outcomes: A Systematic Review of Reviews. PLoS One. 2016; 11(9):e0162198.
    View in: PubMed
    Score: 0.469
  26. Bero L, Anglemyer A, Vesterinen H, Krauth D. The relationship between study sponsorship, risks of bias, and research outcomes in atrazine exposure studies conducted in non-human animals: Systematic review and meta-analysis. Environ Int. 2016 Jul-Aug; 92-93:597-604.
    View in: PubMed
    Score: 0.445
  27. Forsyth SR, Odierna DH, Krauth D, Bero LA. Conflicts of interest and critiques of the use of systematic reviews in policymaking: an analysis of opinion articles. Syst Rev. 2014 Nov 18; 3:122.
    View in: PubMed
    Score: 0.414
  28. Bero L. What is in a name? Nonfinancial influences on the outcomes of systematic reviews and guidelines. J Clin Epidemiol. 2014 Nov; 67(11):1239-41.
    View in: PubMed
    Score: 0.406
  29. Nguyen NY, Bero L. Medicaid drug selection committees and inadequate management of conflicts of interest. JAMA Intern Med. 2013 Mar 11; 173(5):338-43.
    View in: PubMed
    Score: 0.368
  30. Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L. Industry sponsorship and research outcome. Cochrane Database Syst Rev. 2012 Dec 12; 12:MR000033.
    View in: PubMed
    Score: 0.362
  31. Nkansah N, Nguyen T, Iraninezhad H, Bero L. Randomized trials assessing calcium supplementation in healthy children: relationship between industry sponsorship and study outcomes. Public Health Nutr. 2009 Oct; 12(10):1931-7.
    View in: PubMed
    Score: 0.278
  32. White J, Bandura A, Bero LA. Moral disengagement in the corporate world. Account Res. 2009 Jan-Mar; 16(1):41-74.
    View in: PubMed
    Score: 0.275
  33. Cook DM, Boyd EA, Grossmann C, Bero LA. Reporting science and conflicts of interest in the lay press. PLoS One. 2007 Dec 05; 2(12):e1266.
    View in: PubMed
    Score: 0.255
  34. Boyd EA, Bero LA. Defining financial conflicts and managing research relationships: an analysis of university conflict of interest committee decisions. Sci Eng Ethics. 2007 Dec; 13(4):415-35.
    View in: PubMed
    Score: 0.255
  35. Hong MK, Bero LA. Tobacco industry sponsorship of a book and conflict of interest. Addiction. 2006 Aug; 101(8):1202-11.
    View in: PubMed
    Score: 0.233
  36. Bero LA, Glantz S, Hong MK. The limits of competing interest disclosures. Tob Control. 2005 Apr; 14(2):118-26.
    View in: PubMed
    Score: 0.212
  37. Bero LA. Managing financial conflicts of interest in research. J Am Coll Dent. 2005; 72(2):4-9.
    View in: PubMed
    Score: 0.209
  38. Lipton S, Boyd EA, Bero LA. Conflicts of interest in academic research: policies, processes, and attitudes. Account Res. 2004 Apr-Jun; 11(2):83-102.
    View in: PubMed
    Score: 0.198
  39. Boyd EA, Lipton S, Bero LA. Implementation of financial disclosure policies to manage conflicts of interest. Health Aff (Millwood). 2004 Mar-Apr; 23(2):206-14.
    View in: PubMed
    Score: 0.197
  40. Grundy Q, Held F, Hart D, Baugh CM, Ladd E, Campbell E, Bero L. Characteristics of Advanced Practice Nurses Receiving Top Industry Payments and Their Practice Settings: a Cross-sectional Study. J Gen Intern Med. 2024 May; 39(7):1142-1148.
    View in: PubMed
    Score: 0.193
  41. Boyd EA, Cho MK, Bero LA. Financial conflict-of-interest policies in clinical research: issues for clinical investigators. Acad Med. 2003 Aug; 78(8):769-74.
    View in: PubMed
    Score: 0.189
  42. Shamasunder B, Bero L. Financial ties and conflicts of interest between pharmaceutical and tobacco companies. JAMA. 2002 Aug 14; 288(6):738-44.
    View in: PubMed
    Score: 0.177
  43. Soskolne CL, Kramer S, Ramos-Bonilla JP, Mandrioli D, Sass J, Gochfeld M, Cranor CF, Advani S, Bero LA. Toolkit for detecting misused epidemiological methods. Environ Health. 2021 08 19; 20(1):90.
    View in: PubMed
    Score: 0.165
  44. Fabbri A, Nejstgaard CH, Grundy Q, Bero L, Dunn AG, Mohammad A, Mintzes B. Association Between Conflicts of Interest and Authors' Positions on Harms of Varenicline: a Cross-Sectional Analysis. J Gen Intern Med. 2022 02; 37(2):290-297.
    View in: PubMed
    Score: 0.163
  45. Lexchin J, Bero LA, Davis C, Gagnon MA. Achieving greater independence from commercial influence in research. BMJ. 2021 03 09; 372:n370.
    View in: PubMed
    Score: 0.160
  46. Parker L, Grundy Q, Fabbri A, Mintzes B, Bero L. 'Lines in the sand': an Australian qualitative study of patient group practices to promote independence from pharmaceutical industry funders. BMJ Open. 2021 02 09; 11(2):e045140.
    View in: PubMed
    Score: 0.159
  47. Nejstgaard CH, Bero L, Hr?bjartsson A, J?rgensen AW, J?rgensen KJ, Le M, Lundh A. Association between conflicts of interest and favourable recommendations in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: systematic review. BMJ. 2020 12 09; 371:m4234.
    View in: PubMed
    Score: 0.157
  48. Nejstgaard CH, Bero L, Hr?bjartsson A, J?rgensen AW, J?rgensen KJ, Le M, Lundh A. Conflicts of interest in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: associations with recommendations. Cochrane Database Syst Rev. 2020 12 08; 12:MR000040.
    View in: PubMed
    Score: 0.157
  49. Boyd EA, Bero LA. Assessing faculty financial relationships with industry: A case study. JAMA. 2000 Nov 01; 284(17):2209-14.
    View in: PubMed
    Score: 0.156
  50. Turner K, Carboni-Jim?nez A, Benea C, Elder K, Levis B, Boruff J, Roseman M, Bero L, Lexchin J, Turner EH, Benedetti A, Thombs BD. Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study. BMJ Open. 2020 05 11; 10(5):e035633.
    View in: PubMed
    Score: 0.151
  51. Chartres N, Fabbri A, McDonald S, Turton J, Allman-Farinelli M, McKenzie J, Bero L. Association of industry ties with outcomes of studies examining the effect of wholegrain foods on cardiovascular disease and mortality: systematic review and meta-analysis. BMJ Open. 2019 05 19; 9(5):e022912.
    View in: PubMed
    Score: 0.141
  52. Parker L, Karanges EA, Bero L. Changes in the type and amount of spending disclosed by Australian pharmaceutical companies: an observational study. BMJ Open. 2019 02 19; 9(2):e024928.
    View in: PubMed
    Score: 0.139
  53. Fabbri A, Lai A, Grundy Q, Bero LA. The Influence of Industry Sponsorship on the Research Agenda: A Scoping Review. Am J Public Health. 2018 11; 108(11):e9-e16.
    View in: PubMed
    Score: 0.135
  54. Chiu K, Grundy Q, Bero L. 'Spin' in published biomedical literature: A methodological systematic review. PLoS Biol. 2017 Sep; 15(9):e2002173.
    View in: PubMed
    Score: 0.126
  55. Fabbri A, Grundy Q, Mintzes B, Swandari S, Moynihan R, Walkom E, Bero LA. A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia. BMJ Open. 2017 06 30; 7(6):e016701.
    View in: PubMed
    Score: 0.124
  56. Fabbri A, Chartres N, Scrinis G, Bero LA. Study sponsorship and the nutrition research agenda: analysis of randomized controlled trials included in systematic reviews of nutrition interventions to address obesity. Public Health Nutr. 2017 May; 20(7):1306-1313.
    View in: PubMed
    Score: 0.120
  57. Chartres N, Fabbri A, Bero LA. Association of Industry Sponsorship With Outcomes of Nutrition Studies: A Systematic Review and Meta-analysis. JAMA Intern Med. 2016 Dec 01; 176(12):1769-1777.
    View in: PubMed
    Score: 0.119
  58. Barnes DE, Bero LA. Industry-funded research and conflict of interest: an analysis of research sponsored by the tobacco industry through the Center for Indoor Air Research. J Health Polit Policy Law. 1996; 21(3):515-42.
    View in: PubMed
    Score: 0.112
  59. Moynihan R, Nickel B, Hersch J, Beller E, Doust J, Compton S, Barratt A, Bero L, McCaffery K. Public Opinions about Overdiagnosis: A National Community Survey. PLoS One. 2015; 10(5):e0125165.
    View in: PubMed
    Score: 0.107
  60. Krauth D, Anglemyer A, Philipps R, Bero L. Nonindustry-sponsored preclinical studies on statins yield greater efficacy estimates than industry-sponsored studies: a meta-analysis. PLoS Biol. 2014 Jan; 12(1):e1001770.
    View in: PubMed
    Score: 0.098
  61. Bero LA. Why the Cochrane risk of bias tool should include funding source as a standard item. Cochrane Database Syst Rev. 2013 Dec 20; (12):ED000075.
    View in: PubMed
    Score: 0.097
  62. Neltner TG, Alger HM, O'Reilly JT, Krimsky S, Bero LA, Maffini MV. Conflicts of interest in approvals of additives to food determined to be generally recognized as safe: out of balance. JAMA Intern Med. 2013 Dec 9-23; 173(22):2032-6.
    View in: PubMed
    Score: 0.097
  63. Grundy Q, Bero L, Malone R. Interactions between non-physician clinicians and industry: a systematic review. PLoS Med. 2013 Nov; 10(11):e1001561.
    View in: PubMed
    Score: 0.097
  64. Odierna DH, Forsyth SR, White J, Bero LA. The cycle of bias in health research: a framework and toolbox for critical appraisal training. Account Res. 2013; 20(2):127-41.
    View in: PubMed
    Score: 0.091
  65. Roseman M, Turner EH, Lexchin J, Coyne JC, Bero LA, Thombs BD. Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study. BMJ. 2012 Aug 16; 345:e5155.
    View in: PubMed
    Score: 0.088
  66. Norris SL, Burda BU, Holmer HK, Ogden LA, Fu R, Bero L, Sch?nemann H, Deyo R. Author's specialty and conflicts of interest contribute to conflicting guidelines for screening mammography. J Clin Epidemiol. 2012 Jul; 65(7):725-33.
    View in: PubMed
    Score: 0.086
  67. Roseman M, Milette K, Bero LA, Coyne JC, Lexchin J, Turner EH, Thombs BD. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments. JAMA. 2011 Mar 09; 305(10):1008-17.
    View in: PubMed
    Score: 0.080
  68. Bero L, Oostvogel F, Bacchetti P, Lee K. Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others. PLoS Med. 2007 Jun; 4(6):e184.
    View in: PubMed
    Score: 0.062
  69. Cook DM, Bero LA. Identifying carcinogens: the tobacco industry and regulatory politics in the United States. Int J Health Serv. 2006; 36(4):747-66.
    View in: PubMed
    Score: 0.056
  70. Bero LA. Tobacco industry manipulation of research. Public Health Rep. 2005 Mar-Apr; 120(2):200-8.
    View in: PubMed
    Score: 0.053
  71. Pokorny AMJ, Bero LA, Fox P, Karikios DJ, McEwin EJ, Moynihan R, Mintzes B. Interactions between Australian cancer physicians and the pharmaceutical industry: a qualitative study. BMJ Open. 2023 05 26; 13(5):e065719.
    View in: PubMed
    Score: 0.047
  72. Pokorny AMJ, Bero LA, Moynihan R, Mintzes BJ. Industry payments to Australian medical oncologists and clinical haematologists: a cross-sectional analysis of publicly available disclosures. Intern Med J. 2021 Nov; 51(11):1816-1824.
    View in: PubMed
    Score: 0.042
  73. Mialon M, Vandevijvere S, Carriedo-Lutzenkirchen A, Bero L, Gomes F, Petticrew M, McKee M, Stuckler D, Sacks G. Mechanisms for addressing and managing the influence of corporations on public health policy, research and practice: a scoping review. BMJ Open. 2020 07 19; 10(7):e034082.
    View in: PubMed
    Score: 0.038
  74. Benea C, Turner KA, Roseman M, Bero LA, Lexchin J, Turner EH, Thombs BD. Reporting of financial conflicts of interest in meta-analyses of drug trials published in high-impact medical journals: comparison of results from 2017 to 2018 and 2009. Syst Rev. 2020 04 08; 9(1):77.
    View in: PubMed
    Score: 0.038
  75. Barnes DE, Bero LA. Why review articles on the health effects of passive smoking reach different conclusions. JAMA. 1998 May 20; 279(19):1566-70.
    View in: PubMed
    Score: 0.033
  76. Bero LA. Disclosure policies for gifts from industry to academic faculty. JAMA. 1998 Apr 01; 279(13):1031-2.
    View in: PubMed
    Score: 0.033
  77. Lawrence M, Naude C, Armstrong R, Bero L, Covic N, Durao S, Ghersi D, Macdonald G, MacLehose H, Margetts B, Tovey D, Volmink J, Young T. A call to action to reshape evidence synthesis and use for nutrition policy. Cochrane Database Syst Rev. 2016 Nov 21; 11:ED000118.
    View in: PubMed
    Score: 0.030
  78. Stryer D, Bero LA. Characteristics of materials distributed by drug companies. An evaluation of appropriateness. J Gen Intern Med. 1996 Oct; 11(10):575-83.
    View in: PubMed
    Score: 0.029
  79. Grundy Q, Bero LA, Malone RE. Marketing and the Most Trusted Profession: The Invisible Interactions Between Registered Nurses and Industry. Ann Intern Med. 2016 06 07; 164(11):733-9.
    View in: PubMed
    Score: 0.028
  80. Cataldo JK, Bero LA, Malone RE. "A delicate diplomatic situation": tobacco industry efforts to gain control of the Framingham Study. J Clin Epidemiol. 2010 Aug; 63(8):841-53.
    View in: PubMed
    Score: 0.019
  81. Moynihan R, Bero L, Ross-Degnan D, Henry D, Lee K, Watkins J, Mah C, Soumerai SB. Coverage by the news media of the benefits and risks of medications. N Engl J Med. 2000 Jun 01; 342(22):1645-50.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)